FIRST AMENDMENT TO THE LICENSE AGREEMENT
Exhibit 10.2
FIRST AMENDMENT TO THE LICENSE AGREEMENT
This First Amendment to the License Agreement (this "Amendment") is entered into on July 27, 2016 by and between Hadasit Medical Research Services & Development Ltd., of Jerusalem Bio Park, Hadassah Xxx-Xxxxx Xxxxxxx Xxxxxx, X.X.X. 00000, Xxxxxxxxx 91120, Hong Kong University of Science and Technology R and D Corporation Limited, and Artemis Therapeutics Inc., a Delaware corporation, having a place of business at 0000 Xxxxxxxx, Xxx Xxxx, XX 00000 (collectively, the "Parties" or each a "Party").
WHEREAS the Parties have entered into that certain License Agreement on May 31, 2016 (the "Agreement"); and
WHEREAS the Parties wish to amend the Agreement as set forth below.
NOW THEREFORE, in consideration of the foregoing and the mutual agreements, provisions and covenants contained herein, the Parties agree as follows:
1. The second sentence of Section 12.1 shall be deleted in its entirety and replaced by the following:
"Should the Effective Date not occur by August 23, 2016, for any reason whatsoever, this Agreement shall be null and void and of no further effect."
2. This Amendment shall be read together with the Agreement and shall represent the complete current understanding between the Parties hereto with respect to the subject matter hereof. Subject to the modifications contained herein, the provisions of the Agreement shall remain unaltered and in full force and effect.
3. This Amendment may be executed in counterparts and executed signature pages sent by fax and e-mail via PDF all of which taken together shall be deemed to constitute one and the same instrument.
[Signature page follows]
IN WITNESS WHEREOF, the Parties have caused this First Amendment to the License Agreement as of the date hereof.
|
/s/ Xx. Xxxxx Xxx
Hadasit Medical Research
Services & Development Ltd.
By: Xx. Xxxxx Xxx Title: Chief Executive Officer
/s/ Xxxxxx X. Xxxx
Hong Kong University of Science
and Technology R and D
Corporation Limited
By: Xx. Xxxxxx X. Xxxx Title: Chief Executive Officer |
/s/ Xxxxx Xxxxxx
Artemis Therapeutics Inc.
By: Xxxxx Xxxxxx
Title: Director
